Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

Maeve O’Connor – CME Planner
Mylan - Advisory Board/Speaker
Meda – Advisory Board/Speaker
Teva - Advisory Board/Speaker
Kaleo - Advisory Board/Speaker
Merck - Advisory Board/Speaker
Greer - Advisory Board/Speaker
Circassia - Advisory Board/Speaker
Spirometrix - Advisory Board

   
Jennifer Caicedo, MD – CME Planner
Nutricia – Speaker
Mylan – Consultant

Kevin Murphy, MD – Speaker 
Astra Zeneca – Consultant/Advisory Board/Speaker/
Boehringer-Ingelheim – Consultant/Advisory Board/Speaker
Genentech – Consultant/Advisory Board/Speaker
Greer- Consultant/Advisory Board/Speaker
Merck – Consultant/Advisory Board/Speaker
Meda – Consultant/Advisory Board/Speaker
Mylan- Consultant/Advisory Board/Speaker
Novartis – Consultant/Advisory Board/Speaker
Teva – Consultant/Advisory Board/Speaker/Research Grant

Jennifer Leiding, MD - Speaker
Horizon Pharma - Consultant/Advisory Board/Speaker

Luz Fonacier, MD
Genentech - Research and Educational Grants (to Winthrop University Hospital)
Baxter - Research and Educational Grants (to Winthrop University Hospital)
Regeneron – Consultant
Church & Dwight – Consultant

Cheryl Bernstein, RN – Speaker
Dyax – contracted research
Shire – contracted research
Merck- contracted research
GSK - contracted research
Boehringer-Ingelheim - contracted research
Quintiles - contracted research
AstraZeneca - contracted research
Meda - contracted research
Pearl - contracted research
Teva - contracted research
Inflamax - contracted research
Stallergenes - contracted research
Novartis - contracted research
Genentech - contracted research
Circassia - contracted research
Regeneron - contracted research

The following have no relevant financial relationships to disclose:

John Sleasman, MD – Speaker
Tonya Winders, MBA – Speaker
Kay Tyler, RN - Speaker
David Fitzhugh, MD- CME Planner
Sonia Bains, MD – Treasurer NCAAIS (CME Planner/Reviewer)